(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of 9.48% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.25%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.25%.
Mdxhealth Sa's revenue in 2024 is $80,741,000.On average, 2 Wall Street analysts forecast MDXH's revenue for 2024 to be $2,347,594,641, with the lowest MDXH revenue forecast at $2,346,775,998, and the highest MDXH revenue forecast at $2,348,413,284. On average, 2 Wall Street analysts forecast MDXH's revenue for 2025 to be $2,656,768,734, with the lowest MDXH revenue forecast at $2,639,304,355, and the highest MDXH revenue forecast at $2,674,233,114.
In 2026, MDXH is forecast to generate $2,909,456,476 in revenue, with the lowest revenue forecast at $2,909,456,476 and the highest revenue forecast at $2,909,456,476.